MENU
IVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inventiva SA (IVA) Earnings Date & Reports

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH... Show more

A.I. Advisor
published Earnings

IVA is expected to report earnings to fall 4.13% to -19 cents per share on November 23

Inventiva SA IVA Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.34
Q1'26
Beat
by $0.04
Q4'25
Missed
by $0.73
Q3'25
Missed
by $0.01
The last earnings report on September 28 showed earnings per share of -20 cents, beating the estimate of -53 cents. With 2.53M shares outstanding, the current market capitalization sits at 794.23M.
View a ticker or compare two or three
IVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
77
Web
https://www.inventivapharma.com